Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Anna Brujats"

Article category

Keywords

Publication year

"Anna Brujats"

Snapshot

Liver fibrosis, cirrhosis, and portal hypertension

Examining the therapeutic landscape of beta-blockers in portal hypertension
Anna Brujats, Càndid Villanueva
Clin Mol Hepatol 2024;30(4):1055-1059.
Published online March 6, 2024
DOI: https://doi.org/10.3350/cmh.2024.0144

Citations

Citations to this article as recorded by  Crossref logo
  • Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrh
    Georg Semmler, Lorenz Balcar, Mattias Mandorfer
    Clinical and Molecular Hepatology.2025; 31(2): e224.     CrossRef
  • Principles of Non-selective Beta-blocker Usage for Cirrhosis-associated Complications
    Daisy K. Maclaine, Kosha J. Mehta
    SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
  • Treating onychomycosis in diabetic patients: risk, therapy, and topical opportunity
    Aditya K. Gupta, Amanda Liddy, Tong Wang, Su Yong Choi, Elizabeth A. Cooper
    Journal of Dermatological Treatment.2025;[Epub]     CrossRef
  • 14,013 View
  • 108 Download
  • 2 Web of Science
  • Crossref